chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client states she was feeling anxious after receiving the vaccine.  Chielt has a history of anxiety
Patient told us that she got round pink splotches all over her body and on injection site. Her Dr. originally thought it was ringworm, but then spread to entire body. She was given medication for ringworm. The adverse event resolved on its own.
lymph node more sensitive to touch; swollen lymphnode in the left arm where he got the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swollen lymphnode in the left arm where he got the vaccine) and LYMPH NODE PAIN (lymph node more sensitive to touch) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymphnode in the left arm where he got the vaccine). On 13-Apr-2021, the patient experienced LYMPH NODE PAIN (lymph node more sensitive to touch). The patient was treated with IBUPROFEN for Swollen lymph nodes, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymphnode in the left arm where he got the vaccine) and LYMPH NODE PAIN (lymph node more sensitive to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication used.
Pt experienced muscle pain and weakness in upper extremities and cervical area as well as shoulders. Chronic diarrhea. Over the counter diarrhea medication used for treatment of diarrhea. Chronic pain, muscle spasms, muscle tightness, weakness and fatigue treated with prescribed medications.
When I woke up the next morning, my blood sugar had dropped. I did not have a glucometer to measure my blood sugar, by I almost had an episode of syncope at approximately 7:00 am.
hives,joint pain,flu-like sx;seen by MD & treated w/DPH;10JUN94 was resolving;
Pt received immunizations (below) around 4:15pm on 23 Mar 07.  Within 60 minutes of administration, patient broke out in welts/hives all over body.  No difficulty in breathing was noted, but child was taken to the Urgent Care for evaluation/treatment because primary care clinic was closed.  Child was given Benadryl injection and oral steroids for treatment.  Hives/welts have persisted over the past 72 hours despite medications and will worsen if medications are not taken.  Was re-evaluated by Nurse Practitioner for continued welts and was prescribed additional oral medication for his hives/welts.
cried for 1 1/2hrs unable to console;was taken to MD NOV95 p/being brought in for 6mos inj & telling nurse of crying;nurse recommended seeing MD;screamed all day, fever, redness on leg @ inj site;
appointment for the 2nd dose that time so he ended up getting it 5-6 weeks after his 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (appointment for the 2nd dose that time so he ended up getting it 5-6 weeks after his 1st dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (appointment for the 2nd dose that time so he ended up getting it 5-6 weeks after his 1st dose). In March 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (appointment for the 2nd dose that time so he ended up getting it 5-6 weeks after his 1st dose) had resolved.            No concomitant medications were reported. Treatment information was not provided. Lab details were not provided.   This case was linked to MOD-2022-449251 (Patient Link).
sore throat, stiff neck, chills, body aches, nausea, headache (day 2 still have headache), extreme fatigue, swollen lymph nodes, increased blood pressure, night sweats
4 inch area of redness and mild swelling to the right upper arm 2 days after vaccination.  Also headache and subjective fever.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. It was reported that from 14-MAR-2016 to 16-MAR-2016, ZOSTAVAX (lot #L029484, expiration date 06-NOV-2016; lot # L029485, expiration date 06-NOV-2016; lot # L034736, expiration date 09-DEC-2016) were improperly exposed to -12.97 centigrade degree for 9.5 hours and -12.59 centigrade degree for 9.75 hours and -10.79 centigrade degree for 14 hours. Then, on unspecified dates after 16-MAR-2016 (in 2016), the patients were vaccinated with the improperly stored vaccine (dose and route not reported). There were no known adverse effects. This is one of several reports received from the same source. Additional information has been requested.
patient received a dose of Fluarix QIV on 30Oct2023 and then inadvertently was administered a second dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 19-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2023-2024 season) (batch number 7Z423, expiry date 30-JUN-2024) for prophylaxis.   Concomitant products included INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT).   On 14-NOV-2023, the patient received the 2nd dose of Fluarix Quadrivalent 2023-2024 season .5 ml. On 14-NOV-2023, an unknown time after receiving Fluarix Quadrivalent 2023-2024 season, the patient experienced extra dose administered (Verbatim: patient received a dose of Fluarix QIV on 30Oct2023 and then inadvertently was administered a second dose). The outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 16-NOV-2023 A nurse reported that a patient received a dose of Fluarix QIV and then inadvertently was administered a second dose, which led to extra dose administered.  The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
Headache (not a migraine like I get chronically).  Mild start 11pm. Woke me at 5am. Improved with ibuprofen but returned at 12:30 pm later that day.
This spontaneous report as received from a female patient refers to herself of unknown age. On 16-DEC-2014 the patient was vaccinated with M-M-R II (strength, dose, route, lot number not report) advised by her physician (form not reported). The patient reviewed her medical file from her home country. After reviewing her file the patient had already been vaccinated, and this vaccination was a monovalent for each disease measles, mumps, and rubella. Additional information has been requested.
I had the vaccination on 10/23/2022. On 11/23/2022 I started to experience body aches fever diarrhea and headache. I tested COVID-19 Positive on 11/23/2022. I think I have mostly recovered but I still have irregular periods since. I did have experience of heavy menstrual and anal bleeding on 11/26/2022. I was 2 weeks earlier than my regular cycle. I had an emergency colonoscopy in 11/2022. I did have some polyps. I was tested being anemic during this time.
Pt phoned office 11-24-09 of possible reaction to ADACEL on 11-5-09 - C/o joint pain, fever, muscle aches.
The patient complained of pain after receiving J/J covid vaccine. Patient states that the pain in the arm continues to hurt on the next day as well.
SOB, WHEEZING, ELEVATED HR, EPI X1. Evaluated by EMS- Transported to Emergency room/department or urgent care.
her knuckles are puffy; Hand swelling; This is a spontaneous report from a contactable consumer. This 94-year-old female consumer (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EM9809/expiration date: unknown),  via an unspecified route of administration on 03Feb2021 10:20 at single dose (at age of 94 years old) on right arm for covid-19 immunisation at a hospital.  Medical history included hard of hearing for a while and wears hearing aids; she has trouble with her hands (her hands were falling asleep); she has vertigo and she had a stroke and heart attack three years ago, and heart disorder, all from an unknown date and unknown if ongoing. The patient had no prior vaccination within four weeks of COVID-19 vaccine. Concomitant medication included isosorbide 30mg; take one half daily by mouth  for heart and metoprolol 25mg; take one half daily by mouth  for heart and unknown thyroid medication.  The patient experienced right hand swelling on 07Feb2021 with outcome of not recovered , her knuckles are puffy on an unspecified date with outcome of unknown.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/24/20 pfizer,Lot#EK9231 2nd dose 01/13/21Pfizer,lot#EL3248 Diagnosed covid positive:08/02/21 Symptom onset: Exposure:Home Symptoms: Asymptomatic
In the beginning of January, I was feverish, and it felt like a cold. I had postnasal drip. This was about the 2nd and third day. The fever started to break, but I had a cough for a couple of weeks. I was breathing fine and had no weakness. It didn't affect my appetite. When I contacted my doctor, I thought it was flu, but I was positive COVID-19. I was given Paxlovid. It was fine had the metal taste, but it wasn't that bad.
I had periods of dizziness like my atrial fibrillation was acting up every few minutes all day, both days; Left arm was sore for a day; I had periods of dizziness; I was fatigued and took 2 naps each day; This is a spontaneous report from a contactable consumer (patient herself).   An 84-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot number: EN6200), via an unspecified route of administration on the left arm, first dose on 23Feb2021 12:15 at single dose for COVID-19 immunization.  Medical history included atrial fibrillation from an unknown date and allergies to penicillin. The patient is not pregnant. No other vaccine received in four weeks. Concomitant medication included cyanocobalamin (B12-VITAMIIN), vitamin b complex (B COMPLEX), calcium (CALCIUM), ascorbic acid (VIT C), and rivaroxaban (XARELTO) from unspecified dates in two weeks. On 24Feb2021, the patient experienced left arm was sore for a day however the day following the vaccination and the day after that (Wed and Thursday) patient had periods of dizziness like her atrial fibrillation was acting up every few minutes all day, both days. Patient was fatigued and took 2 naps each day. No treatment was received for the AEs. Patient did not have COVID prior vaccination and not tested with COVID post vaccination. The outcome of the event left arm was sore for a day was recovered on 25Feb2021, and for the other events, it was unknown.
At approximately 5:30 PM on November 4, I noticed a bright light in my right field of vision. It was similar to a migraine aura, but without a significant headache, following. The next morning, the visual disturbance persisted, but was slightly less bright. My primary care physician recommended that I see an ophthalmologist immediately. The ophthalmologist ordered item imaging as well as bloodwork to check for possible underlying  cardiac or vascular conditions. Lab work was unremarkable. Retinal imaging showed a small vascular lesion on the right retina consistent with the visual disturbance.
This is a spontaneous report from a contactable consumer reporting on behalf of his son. A 16-month-old, male patient received PREVNAR 13, via an unspecified route of administration on an unknown date in Mar2012 at 1 single dose on an unknown anatomical site for an unspecified indication. The patient medical history was not reported. Sibling information for this three elder brothers was unknown. There were no concomitant medications. Vaccines given on the same day was unknown. Vaccines taken within the last four weeks were none. On an unknown date in Mar2012, it was reported that the patient was administered a bad lot of the vaccine and he experienced a mild fever. Relevant lab data was none. Therapeutic measures were taken as a result of the mild fever and included treatment with TYLENOL. The clinical outcome of the event, mild fever, was recovered on an unknown date in Mar2012. The clinical outcome of the event, the patient was administered a bad lot of the vaccine, was unknown. Follow-up (18MAY2012) Follow-up attempts completed. No further information expected.
Within 24 hours of vaccination, pt developed soreness in R arm (where vaccine was given), generalized weakness and difficulty ambulating, and became nonverbal. Presented to BMC ED with temp 102.5, HR 119, BP 112/62, 97% RA.
but now he hurts whenever he walks or just sitting down it hurts; pain right above his hip that's shooting up to his rib cage, he's in constant pain and it hurts when he walks; pain right above his hip that's shooting up to his rib cage, he's in constant pain and it hurts when he walks; This is a spontaneous report from a sponsored program. This is a report of a contactable male consumer (patient). A 49-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0183; Expiration Date: 31Aug2021), dose 1 via an unspecified route of administration, administered in Arm Left (because his right side is hurting) on 18May2021 12:17 (Age at Vaccination was 49 years) as dose 1, single for COVID-19 immunisation. The patient medical history included COVID-19 (he had COVID before for about 12 hours and he just loss taste and that was it). The patient's concomitant medications were not reported. The patient family medical history was cancer. It was reported that, He was taking the Pfizer Covid vaccine well because science says he has to get it or keep a mask on. He states that, he got it and they had him sit in the room for 15 minutes and he could leave at 12:32. He does have to say props to the needles because they did not hurt whatsoever when it went in his arm, so props for that. He had no previous immunization with the vaccine considered as suspect and no additional vaccines administered on same date of the suspect. He did not receive any other vaccinations within 4 weeks prior to COVID vaccination. The information about other Products received in 2 weeks was not reported. On 18May2021 15:30, the patient experienced pain right above his hip that was shooting up to his rib cage, he was in constant pain, and it hurts when he walks as worsened. When he tries to walk on it, he has to limp. but now he hurts whenever he walks or just sitting down it hurts. He states that he was working until 11:00 and he was sitting down most of the time, but he was still hurting. The patient did not visit an emergency room or physician office as a result of events. But he also stated that, he will go to the emergency room if he still is hurting later. The patient had his next appointment due on 08Jun2021 for his second dose. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
skin on her stomach around to her back is sensitive; skin on her stomach around to her back is painful; Vaccination failure /  7-8 days ago she developed a mild case of shingles; mild case of shingles; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 19th November 2019, the patient received the 2nd dose of Shingrix. On 18th September 2019, the patient received the 1st dose of Shingrix. On 13th January 2021, 421 days after receiving Shingrix and 483 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced sensitive skin and skin pain. On an unknown date, the outcome of the vaccination failure, shingles, sensitive skin and skin pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, sensitive skin and skin pain to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient reported for herself. The patient received 1st and 2nd dose of Shingrix and now 7 to 8 days ago she developed a mild case of shingles. The patient stated that she had no rash or blisters but between 1 and 2 year after receiving 1st and 2nd dose of Shingrix, the skin on her stomach around to her back was sensitive and painful. The physician offered to prescribe antiviral medication, but patient did not want to take antiviral medication. The patient stated that her case was mild. The reporter did not gave consent to follow-up.
Raised rash on back and abdomen - itching. No tx other than OTC BENADRYL. No fever. Mother reports she texted picture of rash to urologist-was told not reaction to BACTRIM.
Rash over chest, under arms, and under breasts, not symptomatic in any way.
It was reported that the patient, who is 11 years old, received the first dose of the Pfizer vaccine on 10/5/2021.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.
Baby heaved and threw up about 10-12 times in 3-4 hours. The first several were breastmilk, the next 4 or 5 were bile, the next several were dry heaving, then there was one more bile, before she fell asleep.
Noted red area to right anterior thigh x 3 days, increased "fussy", no fever, firm elongated erythematous 2 cm area with 0.5 cm vesicular center, firm, no streaking, no edema to thigh, DX-Cellulitis, Tx-Augmentin, Rechecked 07/06/2002- improvement.
Headache, Myalgia, Fever, HYPERtension, employee stated after receiving vaccine had body aches, joint aches, photophobia, headaches, fever, hypertension Narrative:  Employee stated H/A, body aches, joint aches, photopobia, fever, hypertension BP 170/100, employee sent to to ER due to elevated b/p. denies any other symptoms.
Chronic inflammatory demyelinating polyneuropathy; thrombocytopenia; hearing loss; syncope; myopathy; muscle weakness; Information has been received regarding a case in litigation from a lawyer, a male patient (pt) of unknown age, and his spouse. No information was received regarding the pt's past medical history, concurrent conditions, or concomitant medication.  On or about 03-SEP-2013, the pt was administered the zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported).   On unknown dates (reported as "shortly after"), the pt was diagnosed with chronic Inflammatory demyelinating polyneuropathy(CIDP), myopathy, thrombocytopenia, hearing loss (deafness), syncope, and muscle weakness, that resulted in extensive medical treatment (unspecified). It was stated that the symptoms have resulted in serious, progressive, severe, permanent personal and incurable injuries/physical limitations not present prior to using zoster vaccine live (ZOSTAVAX) and that these injuries have resulted in extensive medical treatment and have severely and negatively affected the pt's quality of life, as well as, well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The pt also claimed loss of consortium., loss of services and economic losses (medical expenses; the loss of accumulations). The outcome of the events was not recovered.  The reporter considered all aforementioned events disabling and to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the events chronic inflammatory demyelinating polyradiculoneuropathy, syncope, deafness and thrombocytopenia to be medically significant.
Hives and swelling in hands, feet, tongue, lips and throat.  Two emergency room visits on day after with Epipen and steroids.
Delayed allergic reaction 13 days after receiving 1st dose of Pfizer-BioNTeach Covid-19 Vaccine.  04/27/2021: Received 1st dose, no major side effect. 05/10/2021: Developed itchy red bumps and welts on whole body (torso, scalp etc.) Rash/hives would appear at different areas all day, reduced after sleep hours. Did not realize cause and thought was due to some external allergen, but habits had not varied. 05/14/2021: Realized possible causal connection to MRNA Vaccine. Got antihistamine (Loratadine) and Hydrocortisone cream. Hives still occurred, but managed itchiness and pain. 05/16/2021: Allergic reaction/rashes subsided after 6 days 05/18/2021: Scheduled for 2nd dose of Vaccine after 3 weeks from 1st dose.